News
Pharma ‘shocked’ as drugs cut from Cancer Drugs Fund
Pharma companies have attacked the decision to remove some drugs from England's Cancer Drugs Fund (CDF), in a move aimed at de-listing drugs which don't...
News
Amgen pays Kite Pharma $60 million in CAR T...
Amgen and Kite Pharma are to collaborate on the development of novel Chimeric Antigen Receptor (CAR) T cell immunotherapies based on Kite's engineered autologous cell...
News
Gilead to acquire German Phenex’s FXR programme for liver...
US-based Gilead Sciences has entered into an agreement with German Phenex Pharmaceuticals to acquire its Farnesoid X Receptor (FXR) programme, including small molecule FXR agonists...
News
Pfizer buys Swiss preclinical stage firm Redvax
Pfizer has purchased a controlling stake in Redvax, a spin-off from Swiss biopharmaceutical firm Redbiotec. Terms of the transaction were not disclosed.Redvax...
News
US researchers claim random mutations are responsible for certain...
Scientists from US-based Johns Hopkins Kimmel Cancer Centre have developed a statistical model, which measures the proportion of cancer incidence across many tissue types caused...
News
Mylan and Gilead partner for TAF-based HIV treatments in...
Mylan Laboratories has signed an agreement with Gilead Sciences to increase access to Tenofovir Alafenamide (TAF) based HIV treatments in developing countries. ...
News
AstraZeneca (AZ) and Eli Lilly have started AMARANTH, a...
The trial will examine oral beta secretase cleaving enzyme (BACE) inhibitor AZD3293, also known as LY3314814, which reduced levels of amyloid-beta in the cerebro-spinal fluid...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.